Loading insider details...
Beta
Latest Form 4 (Apr 8, 2026): Exercise/Conversion of 36,459 OABI shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Apr 8, 2026 | OmniAb, Inc. (OABI) | Exercise/Conversion | 36,459 | n/a |
| Feb 18, 2026 | OmniAb, Inc. (OABI) | Exercise/Conversion | 58,333 | n/a |
| Feb 17, 2026 | OmniAb, Inc. (OABI) | Exercise/Conversion | 36,458 | n/a |
| Jan 6, 2026 | Viking Therapeutics, Inc. (VKTX) | Exercise/Conversion | 16,000 | $53.3K |
| Dec 9, 2025 | OmniAb, Inc. (OABI) | Exercise/Conversion | 26,554 | n/a |
| Aug 26, 2025 | OmniAb, Inc. (OABI) | Grant/Award | 540,540 | $1000.0K |
| Apr 14, 2025 | Viking Therapeutics, Inc. (VKTX) | Exercise/Conversion | 20,786 | $166.3K |
| Apr 8, 2025 | OmniAb, Inc. (OABI) | Exercise/Conversion | 36,458 | n/a |
| Feb 20, 2025 | OmniAb, Inc. (OABI) | Exercise/Conversion | 26,549 | n/a |
| Jan 22, 2025 | OmniAb, Inc. (OABI) | Grant/Award | 77,003 | n/a |